# Livzon New North River Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2

> Inspection records and compliance data for Livzon New North River Pharmaceutical Co., Ltd. in Qingyuan, None. Access full analysis and detailed observations.

---

## Details

- Name: Livzon New North River Pharmaceutical Co., Ltd.
- FEI Number: 3005619530
- City: Qingyuan
- State: None
- Country Name: China
- Address Line 1: Renmin One Road
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - Livzon New North River Pharmaceutical Co., Ltd. - 2024-12-20](https://www.keypedia.com/records/483/livzon-new-north-river-pharmaceutical-co-ltd/ad45afaf-9645-4f94-9c36-610869947a38) — source: FDA, date: December 20, 2024
- [FDA Inspection 1260618 - Livzon New North River Pharmaceutical Co., Ltd. - 2024-12-20](https://www.keypedia.com/records/fda_inspections/livzon-new-north-river-pharmaceutical-co-ltd/74bc05d7-54dd-4d79-92ba-87de6e4cada4) — source: FDA, date: December 20, 2024
- [FDA Inspection 1260618 - Livzon New North River Pharmaceutical Co., Ltd. - 2024-12-20](https://www.keypedia.com/records/fda_inspections/livzon-new-north-river-pharmaceutical-co-ltd/009ab383-d3aa-4388-94bf-b1c05c7a7b45) — source: FDA, date: December 20, 2024
- [FDA Inspection 1260618 - Livzon New North River Pharmaceutical Co., Ltd. - 2024-12-20](https://www.keypedia.com/records/fda_inspections/livzon-new-north-river-pharmaceutical-co-ltd/935992c2-cf48-4107-a0ad-d42f1a86f605) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 20, 2024
- [FDA Inspection 1260618 - Livzon New North River Pharmaceutical Co., Ltd. - 2024-12-20](https://www.keypedia.com/records/fda_inspections/livzon-new-north-river-pharmaceutical-co-ltd/5131777c-8989-42ef-9c24-278842d9d269) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 20, 2024
- [483 - Livzon New North River Pharmaceutical Co., Ltd. - 2024-06-20](https://www.keypedia.com/records/483/livzon-new-north-river-pharmaceutical-co-ltd/066cefa0-3b1e-4f48-b1f1-0291451188d7) — source: FDA, date: June 20, 2024
- [FDA Inspection 1095580 - Livzon New North River Pharmaceutical Co., Ltd. - 2019-05-23](https://www.keypedia.com/records/fda_inspections/livzon-new-north-river-pharmaceutical-co-ltd/c71e7ab3-99e6-4bf5-8c09-89b1f982d26d) — classification: No Action Indicated (NAI), source: FDA, date: May 23, 2019
- [FDA Inspection 951219 - Livzon New North River Pharmaceutical Co., Ltd. - 2015-11-06](https://www.keypedia.com/records/fda_inspections/livzon-new-north-river-pharmaceutical-co-ltd/df357c90-731b-4799-8eeb-b4cd1b46a5fe) — classification: No Action Indicated (NAI), source: FDA, date: November 6, 2015
- [FDA Inspection 951219 - Livzon New North River Pharmaceutical Co., Ltd. - 2015-11-06](https://www.keypedia.com/records/fda_inspections/livzon-new-north-river-pharmaceutical-co-ltd/f1d1f865-1b74-49fc-8d86-62572467f35c) — classification: No Action Indicated (NAI), source: FDA, date: November 6, 2015
- [FDA Inspection 824387 - Livzon New North River Pharmaceutical Co., Ltd. - 2013-03-22](https://www.keypedia.com/records/fda_inspections/livzon-new-north-river-pharmaceutical-co-ltd/5915b07e-be60-4cdf-9ccc-6c7b0cc1558e) — classification: No Action Indicated (NAI), source: FDA, date: March 22, 2013
- [FDA Inspection 824387 - Livzon New North River Pharmaceutical Co., Ltd. - 2013-03-22](https://www.keypedia.com/records/fda_inspections/livzon-new-north-river-pharmaceutical-co-ltd/b31c5133-22f7-41c0-b7b0-a011d6c174f4) — classification: No Action Indicated (NAI), source: FDA, date: March 22, 2013
- [FDA Inspection 604389 - Livzon New North River Pharmaceutical Co., Ltd. - 2009-07-16](https://www.keypedia.com/records/fda_inspections/livzon-new-north-river-pharmaceutical-co-ltd/c5f3016f-e37a-4616-8f47-8f516f5af2b6) — classification: Official Action Indicated (OAI), source: FDA, date: July 16, 2009

## Related Companies

- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [Shandong Xinhua Pharmaceutical Company Limited](https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-company-limited/7350901d-493e-45cb-a67f-c73093cf762e)
- [Cambrex Karlskoga AB](https://www.keypedia.com/companies/cambrex-karlskoga-ab/c3f2350f-a38e-4e0c-9bac-e94c0255764c)
- [Neuland Laboratories Limited (Unit I)](https://www.keypedia.com/companies/neuland-laboratories-limited-unit-i/2ab72f34-8d5a-4919-8777-83a4fa3cadd5)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/882d7962-58d4-4de8-9d0b-86bf2cf4773e)
- [Olon S.p.A.](https://www.keypedia.com/companies/olon-spa/7e0ac35e-0f38-43f3-8415-015a3d5c0248)
- [Siegfried PharmaChemikalien Minden Gmbh](https://www.keypedia.com/companies/siegfried-pharmachemikalien-minden-gmbh/711ac70f-e753-40c0-92fd-687cb4eeecc2)
- [AstraZeneca Pharmaceuticals, LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/24c4d7fa-217f-4286-8074-011be79e658f)
- [Ajinomoto Co., Inc.](https://www.keypedia.com/companies/ajinomoto-co-inc/0cddfef7-b7e4-499f-81aa-0d5e77d331d4)
- [Medichem, S.A.](https://www.keypedia.com/companies/medichem-sa/a0e6f1b5-f2ab-4695-a0e9-007630ef1270)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/steven-a-brettler/2a356468-f9da-4b68-a3a1-472567e58e45)